Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
COVID-19: from an acute to chronic disease? Potential long-term health consequences237
Current concepts and advances in biomarkers of acute kidney injury102
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls75
The COVID-19 pandemic: viral variants and vaccine efficacy73
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites73
Potential value and impact of data mining and machine learning in clinical diagnostics62
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review61
Molecular diagnostic assays for COVID-19: an overview52
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath29
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases28
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities27
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research26
Oligoclonal bands: clinical utility and interpretation cues21
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1921
The potential impact of salivary peptides in periodontitis20
Lean and Six Sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory19
T helper cells in depression: central role of Th17 cells19
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future19
Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done19
Personalized reference intervals: from theory to practice17
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology17
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-1917
DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing16
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer16
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)15
Clinical utility of procalcitonin and its association with pathogenic microorganisms14
Progress in understanding COVID-19: insights from the omics approach13
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “postanalytical phase” (WG12
Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis12
Current understanding and controversies on the clinical implications of fibroblast growth factor 2111
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview11
Evaluating thyroid function in pregnant women11
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization11
Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics11
Emerging applications of machine learning in genomic medicine and healthcare11
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure11
Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM11
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications11
0.024614095687866